Beyond The Printed Page

  1. What Can Be Done To Save Biopharma’s Broken Image?
    11/14/2018

    Rob Wright shares a personal anecdote about his experience of breaking into the biopharmaceutical industry, along with insight from three biopharma CEOs on what can be done to save the industry’s

  2. Are You Paying It Forward As A Leader?
    10/22/2018

    Liz Barrett, CEO of Novartis Oncology, discusses taking a proactive approach toward mentoring tomorrow’s leaders.

  3. Novartis Oncology CEO Liz Barrett On Balancing Career And Family
    10/16/2018

    Novartis Oncology CEO, Liz Barrett, on career advancement and family, a common challenge for women in the workplace.

  4. Challenges Of Transformation And Balancing An Internal And External Network From BMS’s Lou Schmukler
    9/24/2018

    Lou Schmukler, president of global product development and supply at Bristol-Myers Squibb, provides a preview as to his approach to transformation the company’s product development and manufacturing operations, along with insight into the world of biopharmaceutical outsourcing.

  5. A Primer On Biopharma Manufacturing From Bristol-Myers Squibb’s Lou Schmukler
    9/17/2018

    Lou Schmukler, president of global product development and supply at Bristol-Myers Squibb, explains some of the nuances between small and large molecule drug manufacturing. 

  6. Amgen’s Acquisition Of Onyx Pharmaceuticals — Through The Eyes Of Tony Coles
    8/27/2018

    Tony Coles, M.D., former CEO of Onyx Pharmaceuticals, provides his perspective on Amgen’s $9.7 billion acquisition of Onyx.

  7. Tony Coles On The Importance Of Courage In Leadership
    8/20/2018

    Tony Coles, M.D., chairman and CEO of Yumanity Therapeutics, discusses the decision to acquire Proteolix for $800 million when serving as the CEO of Onyx Pharmaceuticals.

  8. Tony Coles On The Passing Of A Scientific Icon
    8/13/2018

    Tony Coles, M.D., chairman and CEO of Yumanity Therapeutics, talks about the loss of Susan Lindquist, one of the company’s cofounders.

  9. Sanofi’s Digital Health Guru On Joint Ventures And Finding Top Talent
    7/16/2018

    Ameet Nathwani, M.D., EVP of Sanofi’s medical function, discusses digital health joint venture with Verily Life Sciences, and good places to look for digital health top talent.

  10. Small Clinical Trials Lead To Big Results
    6/25/2018

    In this preview of our July 2018 issue, the CEO of Sage Therapeutics, Jeff Jonas, M.D., elaborates on the company’s approach to developing small clinical trials.